-
effectivehealthcare.ahrq.gov/products/structured-handoff/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-transcript.pdf
May 29, 2025 - What are we doing with the outcome? How
are we going to use what we get from the public?
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker
-
effectivehealthcare.ahrq.gov/products/clinical-care/rapid-research
-
effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/clinician
-
effectivehealthcare.ahrq.gov/products/autism/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-proof_research.pdf
June 01, 2010 - DEcIDE DRN Report 2
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is
part of AHRQ’s Effective Health Care program. It is a collaborative network of research
centers that support the rapid development of new scientific information and analytic
tools. The DEcIDE network assist…
-
effectivehealthcare.ahrq.gov/health-topics/traumatic-brain-injury
-
effectivehealthcare.ahrq.gov/products/family-engagement/protocol
-
effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-2018
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
January 01, 2011 - Prevalence and Medicare reimbursement by recurrent
International Classification of Diseases categories,
2006-2009
Utilization and Costs Data Points #5
In 2009, Medicare reimbursement for
inpatient claims totaled $126.7 billion, more
than 25 percent of which was for circula-
tory diseases. The total per claim r…
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
August 08, 2017 - Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E
Appendix E. Study Char
Appendix E. Study Characteristics Evidence Tables
E-1. NPP
Table E-1. Neuropathic Pain
Author, Year
Country
Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Random…
-
effectivehealthcare.ahrq.gov/products/social-isolation/rapid-product
-
effectivehealthcare.ahrq.gov/news/algorithms
-
effectivehealthcare.ahrq.gov/products/patient-centered-medical-home/research-protocol
-
effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-2017
-
effectivehealthcare.ahrq.gov/products/nursing-staff-shortages/rapid-research
-
effectivehealthcare.ahrq.gov/products/schizophrenia-adult/research-protocol
-
effectivehealthcare.ahrq.gov/products/behavioral-health-screening/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Utilization and cost of anticancer biologic products
among Medicare beneficiaries, 2006-2009
Data Points #6Anticancer Biologics
From 2006 to 2009, over 800,000
Medicare fee-for-service
beneficiaries continuously
enrolled in Parts A and B had a
claim for an anticancer biologic
of interest.
Bevacizumab was the m…